Providing Patient Care Through Community Pharmacies in the UK: Policy,Practice,and Research

Abstract

Spanish

French

Objective:

To describe the provision of patient services through community pharmacies in the UK, with particular reference to England, and to explore the research evidence and policy developments for enhancing the contribution of community pharmacy to primary care and public health.

Findings:

In the UK, National Health Service (NHS) pharmaceutical services are delivered under contract by privately owned community pharmacies. In England, a new 3 tier structure for pharmaceutical services was introduced in 2005 comprising essential, advanced, and enhanced-level services. All NHS pharmacies must deliver 7 essential pharmaceutical services and provide evidence that they meet the requirements of a comprehensive quality assurance framework. In the first year of the contract, around 40% of pharmacies were accredited to undertake medicine use reviews, the first advanced-level service to be implemented. Meanwhile, up to 25% of pharmacies provide a variety of enhanced-level services; the most common of these is supervised administration of methadone as well as support programs for patients quitting smoking. New legislation is being introduced that will accomplish the following: allow pharmacists to acquire independent prescribing rights, require pharmacy technicians to be licensed, necessitate that both pharmacists and pharmacy technicians periodically demonstrate their continuing qualification to practice, and introduce the concept of the “responsible pharmacist” to the operation of community pharmacies.

Discussion:

Community pharmacy is now being recognized by the government as a mainstream contributor to primary care and public health. The current priority is to integrate services provided through community pharmacies into programs provided by other primary care professionals, through strengthening information technology and contractual arrangements. While major changes to the regulation of the pharmacy workforce are occurring, the quality management of community pharmacy services merits further attention.

Conclusions:

The new NHS pharmacy contract and current legislative changes provide a basis for community pharmacy to become fully integrated into NHS long-term care and public health programs.

Keywords

community pharmacy United Kingdom

Get full access to this article

View all access options for this article.

References

The Times atlas of the world. 11th ed. London: Times Books Group Ltd., 2003.

Mullen

Hassell

. The national workforce census: (5) the primary care pharmacy workforce in Britain. Pharmaceut J 2003;271:326–7.

Silcock

Raynor

Petty

. The organisation and development of primary care pharmacy in the United Kingdom. Health Policy 2004;67:207–14.

Department of Health. Response to the Health Select Committee 5th Report of the Session 2002-03 on the control of entry regulations and retail pharmacy services in UK. Cm 5896. London: Stationery Office, 2003.

The National Health Service (Pharmaceutical Services) Regulations 2005. No 641. London: Stationery Office, 2005.

General pharmaceutical services in England and Wales 1996-97 to 2005-06. London: NHS Health and Social Care Information Centre, 2006.

Cunningham-Burley

MacLean

. The role of the chemist in primary health care for children with minor complaints. Soc Sci Med 1987;24:371–7.

Smith

Salkind

. Presentation of clinical symptoms to community pharmacists in London. J Soc Administrative Pharm 1990;7:221–4.

Hassell

Rogers

Noyce

. Community pharmacy as a primary health and self-care resource: a framework for understanding pharmacy utilization. Health Social Care Commun 2000;8:40–9.

10.

Hassell

. Overview of main census findings. Pharmaceut J 2003;270:214–5.

11.

NHS Business Services Authority, Prescription Pricing Division. Drug Tariff April 2007, Part XVI. London: TSO (The Stationery Office), 2007. www.ppa.org.uk/edt/April_2007/mindex.htm (accessed 2007 Apr 12).

12.

Prescriptions dispensed in the community. Statistics for 1995 to 2005: England. Statistical Bulletin 2006/12/HSCIC. London: The Information Centre (Health Care), 2006.

13.

Schafheutle

. Is limiting rather than abolishing prescription charges the answer? Pharmaceut J 2006;276:388–9.

14.

The National Health Service Act 1977. The Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2005. www.dh.gov.uk/assetRoot/04/01/07/59/7/4107597.pdf (accessed 2007 Apr 12).

15.

Hassell

Whittington

Cantrill

Bates

Rogers

Noyce

. Managing demand: transfer of management of self-limiting conditions from general practice to community pharmacies. BMJ 2001;323:146–7.

16.

Pharmacy Practice R&D Task Force (Chairman: Professor Nicholas Mays). A new age for pharmacy practice research: promoting evidence-based practice in pharmacy. London: Royal Pharmaceutical Society of Great Britain, 1997.

17.

Seston

Hassell

Cantrill

Nicolson

Noyce

Schafheutle

. Experiences of establishing and maintaining a community pharmacy research network. Primary Health Care Res Develop 2003;4:245–55.

18.

Sinclair

Bond

Largue

Price

Hannaford

. Community pharmacy provision of allergic rhinitis treatments: a longitudinal study of patient reported outcomes. Int J Pharm Pract 2005;13:249–56.

19.

Whittington

Cantrill

Hassell

Bates

Noyce

. Community pharmacy management of minor conditions in the “Care at the chemist” scheme. Pharmaceut J 2001;266:425–8.

20.

Anderson

Blenkinsopp

Armstrong

. The contribution of community pharmacy to improving the nation's health. Report 1. Evidence from the peer-reviewed literature 1990-2001. London: PharmacyHealthLink/Royal Pharmaceutical Society of Great Britain, 2003.

21.

Blenkinsopp

Anderson

Armstrong

. The contribution of community pharmacy to improving the nation's health. Report 2. Evidence from the UK non-peer-reviewed literature 1990-2001. London: PharmacyHealthLink/ Royal Pharmaceutical Society of Great Britain, 2003.

22.

Maguire

McElnay

Drummond

. A randomised controlled trial of a smoking cessation intervention based in community pharmacies. Addiction 2001;96:325–31.

23.

Sheridan

Strang

Barber

Glanz

. Role of community pharmacies in relation to HIV prevention and drug misuse: findings from the 1995 national survey in England and Wales. BMJ 1996;313:272–4.

24.

Sheridan

Lovell

Turnbull

Parsons

Stimson

Strang

. Pharmacy-based needle exchange (PBNX) schemes in South East England: a survey of service providers. Addiction 2000;95:1551–60.

25.

Bissell

Anderson

. Supplying emergency contraception via community pharmacies in the UK: reflections on the experiences of users and prescribers. Soc Sci Med 2003;57:2367–78.

26.

Bissell

Ward

Noyce

. Variation within community pharmacy. 2. Responding to the presentation of symptoms. J Soc Administrative Pharm 1997;14:105–15.

27.

Watson

Bond

. Evidence-based guidelines for non-prescription treatment of vulvovaginal candidiasis (VVC). Pharm World Sci 2003;25:129–34.

28.

Walker

Watson

Grimshaw

Bond

. Applying the theory of planned behaviour to pharmacists' belief and intentions about the treatment of vaginal candidiasis with non-prescription medicines. Family Pract 2004;21:670–6.

29.

Blenkinsopp

Bradley

. Patients, society and the increase in self-medication. BMJ 1996;312:629–32.

30.

Thomas

DHV

Noyce

. The interface between self-medication and the NHS. BMJ 1996;312:688–91.

31.

Porteous

Ryan

Bond

Hannaford

. Preferences for self-care or professional advice for minor illness: a discrete choice experiment. Br J Gen Pract 2006;57:911–7.

32.

Tully

Hassell

Noyce

. Advice-giving in community pharmacies in the UK. J Health Serv Res Policy 1997;2:38–50.

33.

Hassell

Noyce

Rogers

Harris

Wilkinson

. Advice provided in British community pharmacies: what people want and what people get. J Health Serv Res Policy 1998;3:219–25.

34.

Bissell

Ward

Noyce

. Appropriateness measurement: application to advice-giving in community pharmacy. Soc Sci Med 2000;51:343–59.

35.

Watson

Bond

Grimshaw

Mollinson

Ludbrook

Walker

. Educational strategies to promote evidence-based community pharmacy practice: a cluster randomised controlled trial. Family Pract 2002;19:529–36.

36.

Edmunds

Calnan

. The reprofessionalisation of community pharmacy? An exploration of attitudes to extended roles for community pharmacists amongst pharmacists and General Practitioners in the United Kingdom. Soc Sci Med 2001;53:943–55.

37.

Ryan-Woolley

Cantrill

Noyce

Bennett

Geoghegan

Murphy

. A partnership between community pharmacists and general practitioners in the management of ischaemic heart disease: a feasibility study. Pharmaceut J 2001;267:255–8.

38.

Bond

Matherson

Williams

Donnan

. Repeat dispensing: a role for community pharmacists in controlling and monitoring repeat prescriptions. Br J Gen Pract 2000;50:271–5.

39.

Morecroft

Ashcroft

Noyce

. Repeat dispensing of prescriptions in community pharmacies: a systematic review of the UK literature. Int J Pharm Pract 2006;14:11–9.

40.

Department of Health. Supplementary prescribing by nurses and pharmacists within the NHS in England. A guide for implementation. London: Department of Health, 2003.

41.

Avery

Pringle

. Extended prescribing by UK nurses and pharmacists. BMJ 2005;331:1154–5.

42.

Committee of Inquiry (Chairman: Sir Kenneth Clucas). Pharmacy—report to the Nuffield Foundation. London: The Nuffield Foundation, 1986: 13–53, 131-3.

43.

Department of Health and Social Security. Promoting better health—the government's programme for improving primary care. Cm 249. London: HMSO, 1987.

44.

Department of Health/Royal Pharmaceutical Society of Great Britain Joint Working Party. Pharmaceutical care: the future of community pharmacy. London: Royal Pharmaceutical Society of Great Britain, 1992.

45.

Department of Health. The NHS Plan. A plan for investment, a plan for reform. London: Department of Health, 2000.

46.

Department of Health. Pharmacy in the future—implementing the NHS Plan. London: Department of Health, 2000. www.dh.gov.uk/assetRoot/04/06/82/04/04068204.pdf (accessed 2007 Apr 12).

47.

Scottish Executive. The right medicine—a strategy for pharmaceutical care in Scotland. Edinburgh: Scottish Executive, 2002.

48.

Welsh Assembly Government. Remedies for success—a strategy for pharmacy in Wales. Cardiff: Welsh Assembly Government, 2002.

49.

Department of Health, Social Services and Public Safety (DHSSPSNI). Making it better—a strategy for pharmacy in the community. Belfast: DHSSPSNI, 2004.

50.

Pharmaceutical Services Negotiating Committee. The new contract for community pharmacy. Aylesbury: Pharmaceutical Services Negotiating Committee: 2004. www.psnc.org.uk/uploaded_txt/Pharmacy_contract_summary_(Dec%2004).pdf (accessed 2007 Apr 12).

51.

Department of Health. Health Bill Information Paper: Medicines and pharmacies: making the best use of the pharmacy workforce 2006. www.dh.gov.uk/assetRoot/04/12/62/15/04126215.pdf (accessed 2007 Apr 12).

52.

Health Act 2006(c28); Part 3, Drugs, Medicines and Pharmacies; sections 26-33.

53.

Department of Health. Implementing care closer to home—providing convenient quality care for patients: a national framework for Pharmacists with Special Interests. London: Department of Health, 2006. www.dh.gov.uk/assetRoot/04/13/87/67/04138767.pdf (accessed 2007 Apr 12).

54.

Statutory Instrument 2007 No. 289. The Pharmacists and Pharmacy Technicians Order 2007. London: TSO (The Stationery Office) 2007. www.opsi.gov.uk/si/si2007/20070289.htm (accessed 2007 Apr 12).

55.

Noyce

. Governance and the pharmaceutical workforce in England. Res Soc Admin Pharm 2006;2:408–19.

56.

Community Pharmacy Assurance Framework. NHS Primary Care Contracting 2005. www.primarycarecontracting.nhs.uk/114.php (accessed 2007 Apr 12).

57.

Bradley

Elvey

Ashcroft

Noyce

. Commissioning services and the new community pharmacy contract: (3) Uptake of enhanced services. Pharmaceut J 2006;277:224–6.

58.

Kendall

Sibbald

Ashcroft

. Role and uptake of local pharmaceutical services contracts in commissioning community pharmacy services. Pharmaceut J 2005;274:454–7.

59.

Elvey

Bradley

Ashcroft

Noyce

. Commissioning services and the new community pharmacy contract: (1) Pharmaceutical needs assessments and uptake of new pharmacy contracts. Pharmaceut J 2006;277:161–3.

60.

Bradley

Elvey

Ashcroft

Noyce

. Commissioning services and the new community pharmacy contract: (2) Drivers, barriers and approaches to commissioning. Pharmaceut J 2006;277:189–92.

61.

Elvey

Bradley

Ashcroft

Noyce

. Commissioning services and the new community pharmacy contract: (4) Governance and performance management. Pharmaceut J 2006;277:251–3.

62.

Bradley

Elvey

Ashcroft

Noyce

. Commissioning of community pharmacy services. Manchester: University of Manchester, 2007.

63.

Ashcroft

Morecroft

Parker

Noyce

. Likelihood of reporting adverse events in community pharmacy: an experimental study. Qual Saf Health Care 2006;15:48–52.

64.

Bradley

Elvey

Ashcroft

Noyce

. Commissioning substance misuse services form community pharmacy. Int J Pharm Pract 2006;14(suppl 2):B86–7.

65.

Britton

Scott

. Community pharmacy services to drug misusers in the south-west of England: results of 2003-2004 postal survey. Int J Pharm Pract 2006;14:235–41.

66.

Department of Health. Choosing health through pharmacy—a programme for pharmaceutical public health 2005-2015. London: Department of Health, 2005.

67.

Elvey

Bradley

Ashcroft

Noyce

. Is community pharmacy becoming a sexual health resource? Findings from a national survey of primary care trust commissioners. Int J Pharm Pract 2006;14(suppl 2):B119–20.

68.

Department of Health. Our health, our care, our say: a new direction for community services. Cm 6737. London: TSO (The Stationery Office), 2006.

69.

Blenkinsopp

Celino

. Long term conditions: integration of community pharmacy's contribution. Report 2. London: Royal Pharmaceutical Society of Great Britain, 2006.

70.

Hall

Cantrill

Noyce

. Why don't trained community nurse prescribers prescribe? J Clin Nurs 2006;15:403–12.

71.

Secretary of State for Health. Trust, assurance & safety—the regulation of health professionals in the 21st century. Cm 7013. London: TSO (The Stationery Office) 2007. www.official-documents.gov.uk/document/cm70/7013/7013.pdf (accessed 2007 Apr 12).

72.

Hassell

Shann

. The national workforce census: (1) Locum pharmacists and the pharmacy workforce in Britain. Pharmaceut J 2003;270:658–9.

73.

Magirr

Grimsley

Ottewill

Noyce

. The clinical autonomy of community pharmacists in England. (2) Key findings. Int J Pharm Pract 2004;12:231–8.